Table 2 Levels of immunoglobulins, total protein, complement factors and regulators in ascites fluids

From: Ascitic complement system in ovarian cancer

Diagnosis

No.

IgG (g l−1)

IgM (g l−1)

Protein (g l−1)

C3 (g l−1)

C4 (g l−1)

C1INH (g l−1)

FH/FHL-1 (g l−1)

MCP

DAF

CD59

Ovarian cancer

1

7.698

0.329

84.0

0.466

<0.064

0.127

0.618

+ (U)a

+++

 

2

5.431

0.371

64.0

0.777

0.205

0.253

0.677

+

+

 

3

7.356

0.225

79.5

0.673

0.200

0.159

0.718

+

+++

 

4

5.106

0.211

74.5

0.786

0.136

0.240

1.498

+ (L)

+

 

5

8.409

0.377

91.5

1.388

0.205

0.213

0.473

+

 

6

12.86

0.311

96.5

0.436

0.113

0.201

1.148

++

 

7

7.293

0.315

86.5

0.929

0.190

0.241

0.543

++

 

8

10.00

0.377

64.5

0.900

0.160

0.262

0.767

+

 

9

8.929

0.338

82.5

0.687

0.123

0.198

0.871

+ (U)

++

 

10

13.66

0.659

77.0

0.620

0.102

0.184

1.169

+ (U)

+

 

11

7.825

0.445

91.5

0.898

0.125

0.173

0.375

+ (U)

+

 

12

9.329

0.267

89.5

0.961

0.194

0.215

0.941

++

 

Mean±s.d.

8.66±2.58

0.35±0.12

81.79±10.40

0.79±0.25

0.15±0.05

0.21±0.04

0.758±0.312

   

Other gynaecological neoplasms

13

6.818

0.311

64.5

0.903

0.130

0.215

0.700

++

 

14

38.75

0.516

107.5

0.889

0.104

0.175

0.821

++++

 

15

<0.042

0.710

41.0

0.777

0.131

0.168

0.395

+

 

16

8.071

0.346

84.5

0.772

0.200

0.144

0.424

+++++

Liver failure

17

2.13

0.250

9.3

<0.177

<0.064

<0.031

0.016

 

18

2.74

0.416

7.9

<0.177

<0.064

<0.031

0.050

Serum

NHS

8.0–18.0

0.6–2.7

62–76

0.5–1.5

0.15–0.50

0.12–0.24

0.335–0.587

  1. aU=upper Mw form predominating; L=lower Mw form predominating.
  2. For methods, see Materials and Methods. The values in normal human serum samples are shown for comparison. They represent mean±2 s.d. in 100 healthy blood donors.